Preclinical and clinical studies have shown that the IKK2 inhibitors AS602868 and TPCA-1 induce apoptosis in MM cells by decreasing the canonical NF-κB pathway [27]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.